Clin2
NCT04345406Likely a fitNot yet recruiting

ACE inhibitor medication for treating covid-19

COVID

Treatments studied

Part of Heart & circulation, Infections, Kidney & urinary clinical trials.

This trial tests whether a common blood pressure medication, called an ACE inhibitor, can help treat COVID-19. If you have COVID-19 and are not allergic to this type of drug, you may be able to join.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
60 people
Ages
Any age
Study type
Interventional

Who can take part

  • You have tested positive for COVID-19
  • You are not allergic to ACE inhibitor drugs (for example, lisinopril or enalapril)
  • You do not have a medical condition that makes this medication unsafe for you

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04382846Recruiting· Phase 3
Testing new treatment combinations for COVID-19

This trial studies new drug treatment plans for people who currently have COVID-19. If it works better than standard care, it could improve recovery for patients.

Tanta
NCT04351347Recruiting· Phase 2/Phase 3
Testing higher-dose ivermectin for COVID-19

This trial studies whether a higher dose of ivermectin helps people with COVID-19. It looks at how well the treatment works and whether it causes side effects for participants.

Tanta
NCT04344912Recruiting
Study of COVID-19 effects on heart emergency care

This study looks at how the COVID-19 outbreak affected care for people admitted to the cardiac intensive care unit. It may help hospitals improve how they plan and respond during major outbreaks.

Paris
NCT04983823Recruiting
Study aims to improve long-term heart effects after COVID

This trial looks at how persistent heart-related changes after a past COVID infection may be affected by study treatments. It mainly seeks people who are stable enough for follow-up visits and heart imaging, and who are not already on the specific heart medications required.

Melbourne, Victoria
NCT04367883Recruiting
Study of flu shots and blood-pressure medicines in COVID

This study looks at people who were admitted to the hospital in Terrassa starting in March 2020. Researchers want to see whether having a flu vaccine and using certain blood-pressure medicines (ACE inhibitors or ARBs) is linked to how COVID infection develops.

Terrassa, Barcelona
NCT04790240Recruiting· Phase 1/Phase 2
Herbal treatment aimed to reduce COVID-19 inflammation

This early-stage trial studies whether certain medical herbs can lower inflammation in people with recent COVID-19 and help the immune system better fight the virus. You may be able to join whether or not you take standard COVID medicines, but you would need to complete the herb plan and provide specific lab and scan results.

Rockville, Maryland

Hear when a new COVID trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.